Cargando…

Telavancin: A novel lipoglycopeptide antibiotic

Detalles Bibliográficos
Autores principales:	Damodaran, S. E., Madhan, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications Pvt Ltd 2011
Materias:	Molecules of the Millennium
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3127350/ https://www.ncbi.nlm.nih.gov/pubmed/21772784 http://dx.doi.org/10.4103/0976-500X.81918

Ejemplares similares

Agomelatine: A novel melatonergic antidepressant
por: Manikandan, S
Publicado: (2010)

Lorcaserin: A novel antiobesity drug
por: Brashier, Dick B. S., et al.
Publicado: (2014)

Lifitegrast: A novel drug for treatment of dry eye disease
por: Abidi, Afroz, et al.
Publicado: (2016)

Bedaquiline: A novel drug to combat multiple drug-resistant tuberculosis
por: Goel, Divya
Publicado: (2014)

Sofosbuvir: A novel treatment option for chronic hepatitis C infection
por: Bhatia, Harmeet Kaur, et al.
Publicado: (2014)

Ceftaroline fosamil: A novel anti-Methicillin-resistant Staphylococcus aureus cephalosporin
por: Girish, C., et al.
Publicado: (2011)

Belatacept: A worthy alternative to cyclosporine?
por: Melvin, George, et al.
Publicado: (2012)

Asenapine, a new sublingual atypical antipsychotic
por: Balaraman, R, et al.
Publicado: (2010)

Istaroxime: A rising star in acute heart failure
por: Aditya, Suruchi, et al.
Publicado: (2012)

Boceprevir: A new hope against hepatitis C virus
por: Brashier, Dick B. S., et al.
Publicado: (2012)

Delamanid: A new armor in combating drug-resistant tuberculosis
por: Xavier, Alphienes Stanley, et al.
Publicado: (2014)

Fingolimod (FTY720): First approved oral therapy for multiple sclerosis
por: Sharma, Sushil, et al.
Publicado: (2011)

Belimumab: First targeted biological treatment for systemic lupus erythematosus
por: Dubey, Ashok K., et al.
Publicado: (2011)

Ticagrelor: An emerging oral antiplatelet agent
por: Juneja, Shivani, et al.
Publicado: (2013)

Fospropofol
por: Mahajan, Bharti, et al.
Publicado: (2012)

Macitentan: An important addition to the treatment of pulmonary arterial hypertension
por: Khadka, Anjan, et al.
Publicado: (2015)

Naloxegol: First oral peripherally acting mu opioid receptor antagonists for opioid-induced constipation
por: Anantharamu, Tejus, et al.
Publicado: (2015)

Suvorexant: The first orexin receptor antagonist to treat insomnia
por: Dubey, Ashok K., et al.
Publicado: (2015)

An upcoming drug for onychomycosis: Tavaborole
por: Sharma, Neha, et al.
Publicado: (2015)

Proprotein convertase subtilisin/kexin type 9 enzyme inhibitors: An emerging new therapeutic option for the treatment of dyslipidemia
por: Mazhar, Faizan, et al.
Publicado: (2016)

Telavancin, a new lipoglycopeptide antimicrobial, in complicated skin and soft tissue infections
por: Jafari Saraf, Lida, et al.
Publicado: (2011)

Cellular pharmacokinetics of telavancin, a novel lipoglycopeptide antibiotic, and analysis of lysosomal changes in cultured eukaryotic cells (J774 mouse macrophages and rat embryonic fibroblasts)
por: Barcia-Macay, Maritza, et al.
Publicado: (2008)

The Millennium Project: the positive health implications of improved environmental sustainability
por: Melnick, Don J, et al.
Publicado: (2005)

Disease Emergence and Health Transitions in the Last Millennium
por: Donaldson, Liam
Publicado: (2000)

Will Medicine Be Revolutionised by Genomics?
por: Harris, Rodney
Publicado: (2000)

God, Mammon and the Physician: Medicine in England before the College
por: Rawcliffe, Carole
Publicado: (2000)

Changing Concepts of Health and Disease during the 20th Century
por: Booth, Christopher C
Publicado: (2000)

Imaging in Medicine through the 20th Century
por: Du Boulay, George
Publicado: (2000)

Staphylococcus aureus is able to generate resistance to novel lipoglycopeptide antibiotic gausemycin A
por: Poshvina, Darya V., et al.
Publicado: (2022)

Specific Inhibition of VanZ-Mediated Resistance to Lipoglycopeptide Antibiotics
por: Sur, Vishma Pratap, et al.
Publicado: (2021)

Dalbavancin: A Novel Lipoglycopeptide Antibiotic with Extended Activity Against Gram-Positive Infections
por: Smith, Jordan R., et al.
Publicado: (2015)

Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections
por: Brade, Karrine D., et al.
Publicado: (2016)

Molecules for the millennium: how will they look? New drug discovery year 2000
por: Sausville, E A, et al.
Publicado: (2000)

NaNog: A pluripotency homeobox (master) molecule
por: Allouba, Mona H., et al.
Publicado: (2015)

Engineered biosynthesis of enduracidin lipoglycopeptide antibiotics using the ramoplanin mannosyltransferase Ram29
por: Wu, Ming-Cheng, et al.
Publicado: (2015)

JP Howard Fee MD, PhD, FFARCSI Introduction of The WFK Morrow Lecture
Publicado: (1998)

AA Jennifer Adgey MD, FRCP, FRCPI, FACC Introducion of the Calvert Lecture
Publicado: (1998)

Brian J Rowlands MD, FRCS, FACS Introduction of the Purce Lecture
Publicado: (1998)

The illusion of cell immortality
por: Hayflick, L
Publicado: (2000)

Cancer vaccines
por: Dalgleish, A G
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_nbl2aqrcav4p2r0ts6ouf9ii47